Skip to main content
. Author manuscript; available in PMC: 2015 Oct 15.
Published in final edited form as: Cancer Res. 2014 Aug 27;74(20):5891–5902. doi: 10.1158/0008-5472.CAN-14-0184

Figure 3. β-catenin is activated in human NSCLC tumors harboring EGFR mutants.

Figure 3

(A) Frequency distribution of nuclear β-catenin based on immunohistochemistry on human tissue microarray. P-value was calculated using Fisher's exact test. (B) Frequency of nuclear β-catenin in 4 pairs of pre- and post-TKIs NSCLC tumors. Each symbol represents an individual patient. The detailed information can be found in Supplementary Table. P-value was calculated using Student’s t-test.